News: IQ3 Iq3corp Says Oncotex Got Licensing For A Gold Technology For Immune Response Cancer...

  1. 193,698 Posts.
    lightbulb Created with Sketch. 2825

    Nov 5 (Reuters) - Iq3corp Ltd (IQ3) :

    • ONCOTEX INC, IN WHICH CO HOLDS 40.5% STAKE, GOT LICENSING FOR A GOLD TECHNOLOGY FOR IMMUNE RESPONSE CANCER THERAPY
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.